Picture of Read Gene SA logo

RDG Read Gene SA Cashflow Statement

0.000.00%
pl flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapHigh Flyer

Annual cashflow statement for Read Gene SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.

R2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
PAS
PAS
PAS
PAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line0.0380.213-1.35-1.110.808
Depreciation
Non-Cash Items1.070.3480.5460.4920.173
Unusual Items
Other Non-Cash Items
Changes in Working Capital-1.56-0.669-0.5122.23-1.23
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities0.1060.348-0.8212.090.202
Capital Expenditures-0.06-0.014-0.362-0.338-0.329
Purchase of Fixed Assets
Other Investing Cash Flow Items-3.93-0.8720.287
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-0.06-0.014-4.29-1.21-0.042
Financing Cash Flow Items-0.06-0.225-0.401-0.01-0.331
Other Financing Cash Flow
Net Issuance / Retirement of Debt
Cash from Financing Activities-0.06-0.229-0.401-0.01-0.331
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-0.0140.105-5.510.872-0.171